Friday 6 November 2026
Export CERS’s income statement to Excel — free account
Cerus Corporation
CERS Healthcare Medical Devices
- Revenue
- +6.28%
- EPS
- −2,800.0%
- Free cash flow
- +2,471.3%
- Total debt
- −25.4%
Quarter to September 2026, against a year earlier
2.03
0.10
−4.69%
Follow CERS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 5 | 6 |
| (25.65%) | (15.34%) | (10.69%) | (10.56%) | ||
| (7.39%) | (4.45%) | (3.24%) | (3.48%) | ||
ROIC |
(8.22%) | (2.74%) | (1.27%) | (1.87%) | |
Return on Tangible Assets |
(18.88%) | (12.37%) | (8.38%) | (8.51%) | |
Average Days of Receivables |
47.42 | 43.71 | 45.59 | 44.30 | |
Free Cash Flow per Share |
0.01 | (0.01) | (0.01) | 0.00 | |
Free Cash Flow |
1.11 | (1.22) | (1.83) | 0.49 | |
Capital Expenditures |
(3.73) | (3.85) | (4.25) | (3.00) | |
| Other line items | |||||
Cash ROIC |
0.48% | (0.52%) | (0.95%) | 0.25% | |
Accounts Receivable Turnover |
7.77 | 8.80 | 7.95 | 8.35 | |
Accounts Payable Turnover |
3.78 | 3.42 | 3.32 | 4.27 | |
Inventory Turnover |
1.99 | 1.86 | 1.77 | 1.85 | |
Average Days of Payables |
108.93 | 113.98 | 115.16 | 85.84 | |
Days of Inventory on Hand |
218.20 | 219.16 | 226.12 | 216.37 | |
Tax Rate |
0.02 | 0.04 | 0.06 | 0.05 | |
Research and Development Expense of Revenue |
28.97% | 26.81% | 24.65% | 23.66% | |
Selling, General and Administrative Expense of Revenue |
34.61% | 32.91% | 33.17% | 33.98% | |
Share Based Compensation of Revenue |
9.78% | 8.63% | 8.45% | 8.51% | |
Interest Coverage |
(1.04) | (0.39) | (0.21) | (0.36) | |
Operating CF/Net income |
(0.31) | (0.28) | (0.36) | (0.48) | |
Depreciation/Fixed assets |
0.15 | 0.17 | 0.18 | 0.18 | |
Capex/Depreciation |
(2.61) | (2.46) | (2.52) | (1.74) | |
Revenue per Share |
1.23 | 1.26 | 1.24 | 1.25 | |
Operating CF per Share |
0.03 | 0.01 | 0.01 | 0.02 | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.01) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 |
Columns are period end dates · fundamentals updated 6 Nov 2026